Drilldown: Medicines
Appearance
Medicines > classes:
[[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]]
& fda max
:
10 mg/d
or
5 mg/d 
& fda max
:
10 mg/d
or
5 mg/d 
Use the filters below to narrow your results.
Avoid in second and third trimesters; fetal SGLT2 inhibition disrupts kidney development.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Limited data; switch to insulin where feasible.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
Showing below up to 2 results in range #1 to #2.

